NIAID (National Institute of Allergy and Infectious Diseases)
Scientific/Medical
Scientific/Medical Group Awards
Development of a Monoclonal Antibody to Prevent Malaria Infection Group
In recognition for work on phase 3 of the current malaria vaccine candidate.